Axsome Therapeutics' IPO

Axsome Therapeutics raised a round of funding on November 19, 2015. Investors include Public.

Axsome Therapeutics is a clinical stage biopharmaceutical company developing novel therapies for the management of pain and other central nervous system, or CNS, disorders. By focusing on this therape…

Articles about Axsome Therapeutics' IPO: